Kommagani Ramakrishna, Szwarc Maria M, Kovanci Ertug, Gibbons William E, Putluri Nagireddy, Maity Suman, Creighton Chad J, Sreekumar Arun, DeMayo Francesco J, Lydon John P, O'Malley Bert W
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
PLoS Genet. 2013 Oct;9(10):e1003900. doi: 10.1371/journal.pgen.1003900. Epub 2013 Oct 24.
Early embryo miscarriage is linked to inadequate endometrial decidualization, a cellular transformation process that enables deep blastocyst invasion into the maternal compartment. Although much of the cellular events that underpin endometrial stromal cell (ESC) decidualization are well recognized, the individual gene(s) and molecular pathways that drive the initiation and progression of this process remain elusive. Using a genetic mouse model and a primary human ESC culture model, we demonstrate that steroid receptor coactivator-2 (SRC-2) is indispensable for rapid steroid hormone-dependent proliferation of ESCs, a critical cell-division step which precedes ESC terminal differentiation into decidual cells. We reveal that SRC-2 is required for increasing the glycolytic flux in human ESCs, which enables rapid proliferation to occur during the early stages of the decidualization program. Specifically, SRC-2 increases the glycolytic flux through induction of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3 (PFKFB3), a major rate-limiting glycolytic enzyme. Similarly, acute treatment of mice with a small molecule inhibitor of PFKFB3 significantly suppressed the ability of these animals to exhibit an endometrial decidual response. Together, these data strongly support a conserved mechanism of action by which SRC-2 accelerates the glycolytic flux through PFKFB3 induction to provide the necessary bioenergy and biomass to meet the demands of a high proliferation rate observed in ESCs prior to their differentiation into decidual cells. Because deregulation of endometrial SRC-2 expression has been associated with common gynecological disorders of reproductive-age women, this signaling pathway, involving SRC-2 and PFKFB3, promises to offer new clinical approaches in the diagnosis and/or treatment of a non-receptive uterus in patients presenting idiopathic infertility, recurrent early pregnancy loss, or increased time to pregnancy.
早期胚胎流产与子宫内膜蜕膜化不足有关,子宫内膜蜕膜化是一种细胞转化过程,能使囊胚深入侵入母体组织。尽管支持子宫内膜基质细胞(ESC)蜕膜化的许多细胞事件已广为人知,但驱动这一过程起始和进展的单个基因及分子途径仍不清楚。利用基因小鼠模型和原代人ESC培养模型,我们证明类固醇受体辅激活因子-2(SRC-2)对于ESC依赖类固醇激素的快速增殖不可或缺,这是ESC终末分化为蜕膜细胞之前的关键细胞分裂步骤。我们发现SRC-2是增加人ESC糖酵解通量所必需的,这使得在蜕膜化程序早期能够快速增殖。具体而言,SRC-2通过诱导6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶3(PFKFB3)增加糖酵解通量,PFKFB3是主要的限速糖酵解酶。同样,用PFKFB3小分子抑制剂急性处理小鼠显著抑制了这些动物表现出子宫内膜蜕膜反应的能力。总之,这些数据有力支持了一种保守的作用机制,即SRC-2通过诱导PFKFB3加速糖酵解通量,以提供必要的生物能量和生物量,满足ESC在分化为蜕膜细胞之前观察到的高增殖率需求。由于子宫内膜SRC-2表达失调与育龄妇女常见的妇科疾病有关,这条涉及SRC-2和PFKFB3的信号通路有望为诊断和/或治疗患有特发性不孕症、复发性早期妊娠丢失或受孕时间延长的患者的非容受性子宫提供新的临床方法。